BioCentury | Aug 6, 2020
Product Development

BioNTech testing separate mRNA vaccine variant in Chinese trial, closes supply deal with Canada

...Sandi Wong, Assistant Editor Aviptadil (RLF-100) BNT162b1 BNT162b2 Relief Therapeutics Holding AG NeuroRx Inc. Clinical Reference Laboratory Inc. ImmunityBio Inc. NantKwest Inc. BioNTech SE Pfizer Inc. Shanghai Fosun Pharmaceutical Co. Ltd. COVID-19 cov19sci cov19count cov19dx CHS2020 cov19sci cov19count...
BioCentury | Mar 14, 2018
Financial News

Loncar unveils China BioPharma Index

...NASDAQ:CNCR), which has $60 million in assets (see BioCentury Extra, Oct. 14, 2015) . Amran Gowani BeiGene Ltd. Shanghai Fosun Pharmaceutical Co. Ltd. China Chinese ETF exchange...
BioCentury | Aug 8, 2016
Financial News

Ambrx completes venture financing

...Type: Venture financing Raised: $45 million Investors: Apricot Capital; Northeast Securities; Sinopharm Capital; Humanwell Healthcare; Shanghai Fosun Pharmaceutical Co. Ltd....
Items per page:
1 - 3 of 3
BioCentury | Aug 6, 2020
Product Development

BioNTech testing separate mRNA vaccine variant in Chinese trial, closes supply deal with Canada

...Sandi Wong, Assistant Editor Aviptadil (RLF-100) BNT162b1 BNT162b2 Relief Therapeutics Holding AG NeuroRx Inc. Clinical Reference Laboratory Inc. ImmunityBio Inc. NantKwest Inc. BioNTech SE Pfizer Inc. Shanghai Fosun Pharmaceutical Co. Ltd. COVID-19 cov19sci cov19count cov19dx CHS2020 cov19sci cov19count...
BioCentury | Mar 14, 2018
Financial News

Loncar unveils China BioPharma Index

...NASDAQ:CNCR), which has $60 million in assets (see BioCentury Extra, Oct. 14, 2015) . Amran Gowani BeiGene Ltd. Shanghai Fosun Pharmaceutical Co. Ltd. China Chinese ETF exchange...
BioCentury | Aug 8, 2016
Financial News

Ambrx completes venture financing

...Type: Venture financing Raised: $45 million Investors: Apricot Capital; Northeast Securities; Sinopharm Capital; Humanwell Healthcare; Shanghai Fosun Pharmaceutical Co. Ltd....
Items per page:
1 - 3 of 3